JRO guidance on research during surges of Covid-19

1/ Studies hosted at UCLH.

2/ Studies where the sponsor is UCL and UCLH sponsored studies.

3/ Monitoring visits at UCLH.

Further information can also be found on our Covid-19 web pages.

The guidance documents have not changed from those circulated earlier this year and should continue to be applied for all future surges and/or where Covid related activity impacts NHS clinical delivery.

Please do follow the appropriate guidance for the study:

• Studies sponsored by UCL or UCLH with sites outside of UCLH should follow the guidance against point 2 (in the list above) and the local policy/guidance of the host NHS or Social Care organisations.
• Studies sponsored by UCL or UCLH and where the site is UCLH should follow guidance 1, 2 and where applicable guidance 3
• Studies sponsored by an organisation outside of UCL and UCLH and where UCLH is a site, should follow guidance 1 and where applicable guidance 3.

Studies which are supported by a UCL Clinical Trials Unit (CTU) should consult with the CTU point of contact prior to initiating guidance 2.

Should there be any change to the guidance the JRO will email all researchers and research groups and will update the JRO website.

To be included in future communications about Covid-19 and research, please email uclh.jro-communications@nhs.net and ask to be included in the researchers’ distribution list.

For any questions email Rajinder Sidhu on r.sidhu@nhs.net and Pushpsen Joshi on pushpsen.joshi@nhs.net.